Adimmune Corp Financials
| 4142 Stock | TWD 21.80 0.40 1.80% |
Adimmune |
Understanding current and past Adimmune Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Adimmune Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Adimmune Corp's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Adimmune Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Adimmune Corp. Check Adimmune Corp's Beneish M Score to see the likelihood of Adimmune Corp's management manipulating its earnings.
Adimmune Corp Stock Summary
Adimmune Corp competes with Medigen Vaccine, SCI Pharmtech, Chunghwa Chemical, ScinoPharm Taiwan, and Abnova Taiwan. Adimmune Corporation manufactures and sells human vaccines in Taiwan. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan. ADIMMUNE CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. It employs 384 people.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | TW0004142005 |
| Business Address | No 3, Tanxing |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.adimmune.com.tw |
| Phone | 886 4 2538 1220 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Adimmune Corp without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Adimmune Stock, because this is throwing your money away. Analyzing the key information contained in Adimmune Corp's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Adimmune Corp Key Financial Ratios
There are many critical financial ratios that Adimmune Corp's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Adimmune Corp reports annually and quarterly.| Return On Equity | 0.0655 | |||
| Return On Asset | 0.0139 | |||
| Target Price | 35.0 | |||
| Number Of Employees | 36 | |||
| Beta | 0.54 |
Adimmune Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Adimmune Corp's current stock value. Our valuation model uses many indicators to compare Adimmune Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adimmune Corp competition to find correlations between indicators driving Adimmune Corp's intrinsic value. More Info.Adimmune Corp is rated second in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about 0.21 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Adimmune Corp is roughly 4.71 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Adimmune Corp's earnings, one of the primary drivers of an investment's value.Adimmune Corp Systematic Risk
Adimmune Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Adimmune Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Adimmune Corp correlated with the market. If Beta is less than 0 Adimmune Corp generally moves in the opposite direction as compared to the market. If Adimmune Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Adimmune Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Adimmune Corp is generally in the same direction as the market. If Beta > 1 Adimmune Corp moves generally in the same direction as, but more than the movement of the benchmark.
Adimmune Corp March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Adimmune Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Adimmune Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Adimmune Corp based on widely used predictive technical indicators. In general, we focus on analyzing Adimmune Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Adimmune Corp's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.22 | |||
| Information Ratio | 0.108 | |||
| Maximum Drawdown | 17.07 | |||
| Value At Risk | (3.29) | |||
| Potential Upside | 9.83 |
Additional Tools for Adimmune Stock Analysis
When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.